Harrow, Inc. (HROW)
35.01
+1.01
(+2.97%)
USD |
NASDAQ |
Mar 24, 13:33
Harrow Total Liabilities (Quarterly) : 353.12M for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Corcept Therapeutics, Inc. | 190.22M |
| Esperion Therapeutics, Inc. | 1.186B |
| Regeneron Pharmaceuticals, Inc. | 9.302B |
| Theravance Biopharma, Inc. | 188.85M |
| Rhythm Pharmaceuticals, Inc. | 342.12M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 405.21M |
| Shareholders Equity (Quarterly) | 52.45M |
| Debt to Equity Ratio | 4.804 |
| Current Ratio | 2.199 |
| Net Debt Paydown Yield | -0.61% |